Lawsuits filed across the country, including multidistrict litigation in federal court, allege that pharmaceutical companies like Novo Nordisk and Eli Lilly failed to properly warn patients and healthcare providers about these dangers
These treatments are not recommended for people with personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or during pregnancy
Clinical comparison shows approximately 1% weight loss with Gentle Patches versus 15% with prescription GLP-1 medications like Wegovy
Metabolic health research protocol Beyond weight management, retatrutide showed remarkable improvements in metabolic markers
Novo Nordisk specifically requested that the administration address imported generic semaglutide, which is being shipped in very sketchy pallets (bolding mine): the Partnership for Safe Medicines found that product codes and paperwork accompanying foreign, non-Novo Nordisk sourced API presented for entry into our country contained numerous red flags. For example, shipments listed unlikely manufacturers, such as a major hotel chain, a fitness center, and a public school in Canada
A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that reports of overdoses of popular injectable weight-loss medications to a regional poison control center have increased substantially over the last few years